[1]
“Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade”, Swiss Med Wkly, vol. 147, no. 4748, p. w14544, Nov. 2017, doi: 10.4414/smw.2017.14544.